King Charles strips Prince Andrew of his royal titles, effectively ending his public royal life amid renewed scrutiny over his ties to convicted sex offender Jeffrey Epstein.
Proxy adviser ISS recommends rejecting CoreWeave's $9 billion bid to acquire Core Scientific, citing concerns over the "rushed sale process" and "fixed exchange ratio" that undervalue Core Scientific.
King Charles strips Prince Andrew of his royal titles, effectively ending his public royal life amid renewed scrutiny over his ties to convicted sex offender Jeffrey Epstein.
Proxy adviser ISS recommends rejecting CoreWeave's $9 billion bid to acquire Core Scientific, citing concerns over the "rushed sale process" and "fixed exchange ratio" that undervalue Core Scientific.